Feed PMCUF
PM

Pro Medicus Limited PMCUF OTC · Healthcare · Australia

$136.55 +0.00% +$0.00

Summary

79 / 100 · Bulios Score

What speaks for it

  • Earnings per share grew by 63% a year over the last 3 years.
  • Out of every 100 AUD of revenue, 101 AUD is left as net profit.
  • It earns 25 AUD a year on every 100 AUD of invested capital.
  • It holds more cash than debt: $146.3M against $2.23M.

What to watch

  • The share price is above the Bulios Fair Price.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Bulios Fair Price
Overvalued Price today $136.55

By our assumptions the business is worth less than its shares cost today.

P/E today 79.8
Medical - Healthcare Information Services industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 79.8 AUD for 1 AUD of yearly profit.

Valuation in detail

Is it growing?

Yes, fast

Revenue (AUD)

Diluted EPS (AUD)

  • Analyst estimate

Revenue grew by 31% a year over 5 years. Over the last 3 years it grew by 28% a year. For the next fiscal year analysts expect revenue to grow by 27%. Earnings per share grew by 63% a year over the last 3 years.

Growth in detail

Does it make money?

Very well

Where 100 AUD of revenue goes

Net profit, industry median (Medical - Healthcare Information Services) 5.7 AUD

Out of every 100 AUD of revenue, 101 AUD is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

It could repay all its debt from a single year of free cash flow. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

Small, safe
Yield
0.39%
Paid out of profit
31%
Raised in a row
5 years

You receive $0.53 per share a year. The company covers the payout with ease.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Today's price within the analysts' price targets

The average target of $155 is 14% above today's price.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy